Who owns MOONLAKE IMMUNOTHERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Moonlake Immunotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Moonlake Immunotherapeutics stock

Who bought or sold MOONLAKE IMMUNOTHERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Simplex Trading 114k $1.5M -44% Dec 2025
 View chart
IMC-Chicago 68k $890k 24% Dec 2025
 View chart
Group One Trading 60k $786k -64% Dec 2025
 View chart
Persistent Asset Partners 126.00 $30k 107% Dec 2025
 View chart

Who sold out of Moonlake Immunotherapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Silverarc Capital Management Sep 2025 65k $466k